Polar Asset Management Partners Inc. Iovance Biotherapeutics, Inc. Transaction History
Polar Asset Management Partners Inc.
- $4.67 Billion
- Q2 2025
A detailed history of Polar Asset Management Partners Inc. transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Polar Asset Management Partners Inc. holds 433,900 shares of IOVA stock, worth $1.01 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
433,900Holding current value
$1.01 Million% of portfolio
0.02%Shares
4 transactions
Others Institutions Holding IOVA
# of Institutions
292Shares Held
233MCall Options Held
1.14MPut Options Held
1.15M-
Mhr Fund Management LLC New York, NY29MShares$67.2 Million8.78% of portfolio
-
Vanguard Group Inc Valley Forge, PA25.1MShares$58.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$49.2 Million0.0% of portfolio
-
Long Focus Capital Management, LLC San Juan, PR11.8MShares$27.4 Million0.94% of portfolio
-
State Street Corp Boston, MA9.89MShares$22.9 Million0.0% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $366M
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...